A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants With Severe Asthma Who Completed the VALIANT Trial
A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants With Severe Asthma Who Completed the VALIANT Trial
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT study (NCT06196879).
Inclusion Criteria:
Exclusion Criteria:
Farmington Hills, Michigan 48336, United States
CABA, Argentina C1121ABE, Argentina
Córdoba, Córdoba Province X5003DCE, Argentina
San Miguel de TucumƔn, TucumƔn Province CP T4000IAP, Argentina
Rousse, Ruse 7000, Bulgaria
Sofia, Sofia 1407, Bulgaria
Sofia, Sofia 1680, Bulgaria
ValparaĆso, Valparaiso 2531172, Chile
Hamburg, Free and Hanseatic City of Hamburg 22299, Germany
Hessen, Germany 60596, Germany
Hokkaido, Hokkaido 053-8506, Japan
Wroclaw, Dolnoslaskie Voivodeship 53-201, Poland
Krakow, Malopolskie Voivodeship 31-141, Poland
Krakow, Malopolskie Voivodeship 31-624, Poland
Tarnów, Malopolskie Voivodeship 33-100, Poland
Gdansk, Pomorskie Voivodeship 80-214, Poland
Ostrowiec ÅwiÄtokrzyski, ÅwiÄtokrzyskie Voivodeship 27-400, Poland
Seoul, Republic of Korea 06591, South Korea
Chernivtsi, Chernivtsi Oblast 58000, Ukraine
Ivano-Frankivsk, Ivano-Frankivsk Oblast 76018, Ukraine
Cottingham, East Yorkshire HU16 5JQ, United Kingdom
Glasgow, Scotland G12 0YN, United Kingdom